Preparation and evaluation of oral capsules containing apigenin nanocrystals prepared by ultrasonication

Mahmood A. Haiss; Nidhal K. Maraie

doi:10.32947/ajps.v21i3.793

Authors

Mahmood A. Haiss Departement of Pharmaceutics, College of pharmacy, Mustansiriyah University, Baghdad, Iraq
Nidhal K. Maraie Departement of Pharmaceutics, College of pharmacy, Mustansiriyah University, Baghdad, Iraq

DOI:

https://doi.org/10.32947/ajps.v21i3.793

Abstract

This work aims to enhance dissolution rate, increase absorption and bioavailability of Apigenin by formulating it as nanocrystal suspension employing ultrasonic technology. Two different diluents; (5%, 10%) microcrystalline cellulose (MCC) and (2%, 3%) anhydrous lactose were used to prepare hard gelatin

capsules for two optimum types for apigenin nanocrystals prepared in our laboratory utilizing ultrasonication technique using 1% tween 80 (F6) and 2% poloxamer 188 (F20). The results showed that the marketed capsules (containing MCC) had about half the dissolution rate than all the prepared nanocrystals capsules formulas, and the nanocrystals prepared with poloxamer gave 90% release within 20 minutes and 100% release with 2 hours with excellent flow properties with no effect of the added diluents while the addition of diluents improved significantly the release of nanocrystals capsules (F6) with 1% tween 80 with good flow properties. The results suggested that utilizing apigenin nanocrystals prepared by ultrasonication technique may improve drug absorption and bioavailability with a reduced required dose.

References

- Jones, B, E. Pharmaceutical Capsules 2 edition. Edited by Podczeck, F., Jones, B, E. Pharmaceutical Press. London. 2004; pp1; 2; 9; 17; 91; 242; 449.

- Podczeck, F. Pharmaceutical Capsules 2 edition. Edited by Podczeck, F.,Jones, B, E. Pharmaceutical Press. London. 2004; pp103;119; 120.nd

- Jones, B. E. Pharmaceutics the science of dosage form design. 2 M. E. Aulton; Churchill Livingstone. 2002; pp 454; 456; 457; 458.

- JONAT, S., HASENZAHL, S., DRECHSLER, M., ALBERS, P., WAGNER, K. G., SCHMIDT, P. C. Investigation of compacted hydrophilic and hydrophobic colloidal silicon dioxides as glidants for pharmaceutical excipients. Powder Technology. 2004; 141, 31-43. DOI: https://doi.org/10.1016/j.powtec.2004.01.020

- Don M. Pirro; Martin Webster; Ekkehard Daschner. Lubrication Fundamentals (Third Edition, Revised and Expanded ed.); 2016. DOI: https://doi.org/10.1201/b19217

- Salehi B, Venditti A, Sharifi-Rad M, Kręgiel D, Sharifi-Rad J, Durazzo A, Lucarini M, Santini A, Souto EB, Novellino E, Antolak H, Azzini E, Setzer WN, Martins N. The Therapeutic Potential of Apigenin. International Journal of Molecular Sciences. 2019; 20(6):1305. DOI: https://doi.org/10.3390/ijms20061305

- Zheng Y-Z, Chen D-F, Deng G, Guo R. The Substituent Effect on the Radical Scavenging Activity of Apigenin. Molecules. 2018; 23(8):1989. DOI: https://doi.org/10.3390/molecules23081989

- Xiao-Qin Ma, Chong Zhuang, Bi-Chuan Wang, Yuan-Feng Huang, Qing Chen, Ning Lin. Cocrystal of apigenin with higher solubility, enhanced oral bioavailability, and anti-inflammatory effect. Crystal Growth & Design. 2019; 19 (10), 5531-5537. DOI: https://doi.org/10.1021/acs.cgd.9b00249

- Md Yousof Ali, Susoma Jannat, M Mizanur Rahman. Investigation of C- glycosylated apigenin and luteolin derivatives’ effects on protein tyrosine phosphatase 1B inhibition with molecular and cellular approaches. Computational Toxicology. 2021; 17, 100141. DOI: https://doi.org/10.1016/j.comtox.2020.100141

- Jian-Ge Qiu, Lin Wang, Wen-Jing Liu, Ju-Feng Wang, Er-Jiang Zhao, Feng- Mei Zhou, Xiang-Bo Ji, Li-Hong Wang, Zhong-Kun Xia, Wei Wang, Marie Chia- mi Lin, Ling-Zhi Liu, Ying-Xue Huang, Bing-Hua Jiang. Apigenin inhibits IL- transcription and suppresses esophageal carcinogenesis. Frontiers in pharmacology. 2019; 10, 1002. DOI: https://doi.org/10.3389/fphar.2019.01002

- J. Zhang, D. Liu, Y. Huang, Y. Gao, S. Qian, Biopharmaceutical classification and intestinal absorption study of apigenin, Int. J. Pharm, 2012; 436(1): 311-317. DOI: https://doi.org/10.1016/j.ijpharm.2012.07.002

- Mahajan NM, Malghade AD, Dumore NG, Thenge RR. Design and Development of Cristallo-co-agglomerates of Ritonavir for the Improvement of Physicochemical Properties. Turk J Pharm Sci. 2018; 15(3): 248-255. DOI: https://doi.org/10.4274/tjps.44227

- Sultan M Alshehri, Faiyaz Shakeel, Mohamed A Ibrahim, Ehab M Elzayat, Mohammad Altamimi, Kazi Mohsin, O said T Almeanazel, Musaed Alkholief, Abdullah Alshetaili, Bader Alsulays, Fars K Alanazi, Ibrahim A Alsarra. Dissolution and bioavailability improvement of bioactive apigenin using solid dispersions prepared by different techniques. Saudi Pharmaceutical Journal, 2019; 27(2): 264-273. DOI: https://doi.org/10.1016/j.jsps.2018.11.008

- Weiwei Wu, Yuangang Zu, Xiuhua Zhao, Xinxin Zhang, Lingling Wang, Yuanyuan Li, Li Wang, Yin Zhang, Bolin Lian. Solubility and dissolution rate improvement of the inclusion complex of apigenin with 2-hydroxypropyl-β cyclodextrin prepared using the liquid antisolvent precipitation. Drug Development and Industrial Pharmacy, 2017;43(8): 1366-1377. DOI: https://doi.org/10.1080/03639045.2017.1318900

- Jianjun Zhang, Yanting Huang, Dapeng Liu, Yuan Gao, Shuai Qian. Preparation of apigenin nanocrystals using the supercritical antisolvent process for dissolution and bioavailability enhancement. European Journal of Pharmaceutical Sciences,2013; 48(6): 740–747.

- Vijay Agarwal, Meenakshi Bajpai. Preparation and optimization of esomeprazole nanosuspension using evaporative precipitation–ultrasonication. Tropical Journal of Pharmaceutical Research. 2014; 13 (4): 497-503 DOI: https://doi.org/10.4314/tjpr.v13i4.2

- United States Pharmacopeia (USP 30) and the 25th edition of the National Formulary (NF25). USA: United States pharmacopeial convention publishing; 2007.

- Reddy V., Syed M., Rao D. S. Formulation and Evaluation of Colon Targeted Oral Drug Delivery System for Meloxicam. Scholars Academic Journal of Pharmacy. 2015; 4(1): 1-9.

- Gandhi A. Mouth dissolving tablets: a new venture in modern formulation technology. The pharma innovation. 2012; 1(8): 14-31.

- Allen, Loyd V, Popovich, Nicholas G, Ansel, Howard C. Ansel's pharmaceutical dosage forms and drug delivery systems. Ninth Edition. Lippincott Williams & Wilkins; 2011.

- Jianjun Zhang, Yanting Huang, Dapeng Liu, Yuan Gao, Shuai Qian. Preparation of apigenin nanocrystals using the supercritical antisolvent process for dissolution and bioavailability enhancement. European Journal of Pharmaceutical Sciences; 2013; 48 (4-5), 740-747. DOI: https://doi.org/10.1016/j.ejps.2012.12.026

- Jianwen Li, Qiang Fu, Xiaohong Liu, Mo Li, Yongjun Wang. Formulation of nimodipine nanocrystals for oral administration. Archives of 98Pharmacal research. 2016; 39 (2), 202-212. DOI: https://doi.org/10.1007/s12272-015-0685-5

- Jaleh Varshosaz, Sharareh Eskandari, Majid Tabakhian. Production and optimization of valproic acid nanostructured lipid carriers by the Taguchi design. Pharmaceutical development and technology. 2010; 15 (1), 89-96. DOI: https://doi.org/10.3109/10837450903013568